Although pharmaceuticals are the main treatment route, medical devices are needed to fight the disease on a new level.
The need is growing for life-saving treatments.
In the quest for faster, more accurate results, these products will have a tremendous impact on diagnosing infectious diseases.
Changes in financial reporting can be an annual disruption for medical device companies. But the impact of recent changes to financial accounting standards is likely the most sweeping since the passage of the Sarbanes Oxley Act of 2002.
Access to the IVD market in China is lengthy and complicated.
When applicable, the process provides novel products with a speedier route to market.
No longer just the domain of bitcoin pundits and tech cowboys, blockchain technology has very real implications for the healthcare ecosystem—if we’re willing to give it a go.
Although healthcare industry tends to be slow to adopt new technologies, device companies should seriously consider the potential of blockchain.
The president’s tariffs on imports, especially steel and aluminum, could increase input production costs, making products more expensive.
The agency wants to make sure that all patients receive information about the risks of the female contraception device prior to implantation.